These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32915193)

  • 1. The tryptophan biosynthetic pathway is essential for Mycobacterium tuberculosis to cause disease.
    Lott JS
    Biochem Soc Trans; 2020 Oct; 48(5):2029-2037. PubMed ID: 32915193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in
    Negatu DA; Yamada Y; Xi Y; Go ML; Zimmerman M; Ganapathy U; Dartois V; Gengenbacher M; Dick T
    mBio; 2019 Mar; 10(2):. PubMed ID: 30914514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing.
    Zhang YJ; Reddy MC; Ioerger TR; Rothchild AC; Dartois V; Schuster BM; Trauner A; Wallis D; Galaviz S; Huttenhower C; Sacchettini JC; Behar SM; Rubin EJ
    Cell; 2013 Dec; 155(6):1296-308. PubMed ID: 24315099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of Mycobacterium tuberculosis to indole 4-carboxamides occurs through alterations in drug metabolism and tryptophan biosynthesis.
    Libardo MDJ; Duncombe CJ; Green SR; Wyatt PG; Thompson S; Ray PC; Ioerger TR; Oh S; Goodwin MB; Boshoff HIM; Barry CE
    Cell Chem Biol; 2021 Aug; 28(8):1180-1191.e20. PubMed ID: 33765439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Biotin Biosynthetic Pathway in Mycobacterium tuberculosis is a Validated Target for the Development of Antibacterial Agents.
    Bockman MR; Mishra N; Aldrich CC
    Curr Med Chem; 2020; 27(25):4194-4232. PubMed ID: 30663561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric inhibitors of Mycobacterium tuberculosis tryptophan synthase.
    Michalska K; Chang C; Maltseva NI; Jedrzejczak R; Robertson GT; Gusovsky F; McCarren P; Schreiber SL; Nag PP; Joachimiak A
    Protein Sci; 2020 Mar; 29(3):779-788. PubMed ID: 31930594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing the chemical scaffold of the anti-arthritic drug Lobenzarit to target tryptophan biosynthesis in Mycobacterium tuberculosis.
    Evans GL; Gamage SA; Bulloch EM; Baker EN; Denny WA; Lott JS
    Chembiochem; 2014 Apr; 15(6):852-64. PubMed ID: 24623674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection.
    Giraud-Gatineau A; Coya JM; Maure A; Biton A; Thomson M; Bernard EM; Marrec J; Gutierrez MG; Larrouy-Maumus G; Brosch R; Gicquel B; Tailleux L
    Elife; 2020 May; 9():. PubMed ID: 32369020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium sulfur metabolism and implications for novel drug targets.
    Zeng L; Shi T; Zhao Q; Xie J
    Cell Biochem Biophys; 2013 Mar; 65(2):77-83. PubMed ID: 23054909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of Fluorinated Anthranilate-Induced Growth Inhibition in Mycobacterium tuberculosis.
    Nurul Islam M; Hitchings R; Kumar S; Fontes FL; Lott JS; Kruh-Garcia NA; Crick DC
    ACS Infect Dis; 2019 Jan; 5(1):55-62. PubMed ID: 30406991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and inhibition of subunit I of the anthranilate synthase complex of Mycobacterium tuberculosis and expression of the active complex.
    Bashiri G; Johnston JM; Evans GL; Bulloch EM; Goldstone DC; Jirgis EN; Kleinboelting S; Castell A; Ramsay RJ; Manos-Turvey A; Payne RJ; Lott JS; Baker EN
    Acta Crystallogr D Biol Crystallogr; 2015 Nov; 71(Pt 11):2297-308. PubMed ID: 26527146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of anthranilate synthase component I (TrpE) from Mycobacterium tuberculosis H37Rv.
    Lin X; Xu S; Yang Y; Wu J; Wang H; Shen H; Wang H
    Protein Expr Purif; 2009 Mar; 64(1):8-15. PubMed ID: 18952181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
    Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
    PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
    Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
    FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis.
    Bisson GP; Mehaffy C; Broeckling C; Prenni J; Rifat D; Lun DS; Burgos M; Weissman D; Karakousis PC; Dobos K
    J Bacteriol; 2012 Dec; 194(23):6441-52. PubMed ID: 23002228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection.
    Blumenthal A; Nagalingam G; Huch JH; Walker L; Guillemin GJ; Smythe GA; Ehrt S; Britton WJ; Saunders BM
    PLoS One; 2012; 7(5):e37314. PubMed ID: 22649518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.